251 related articles for article (PubMed ID: 19638450)
1. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.
Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ
Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H
Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596
[TBL] [Abstract][Full Text] [Related]
3. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
[TBL] [Abstract][Full Text] [Related]
4. Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro.
Wu X; Sooman L; Wickström M; Fryknäs M; Dyrager C; Lennartsson J; Gullbo J
Mol Cancer Ther; 2013 Aug; 12(8):1526-36. PubMed ID: 23699657
[TBL] [Abstract][Full Text] [Related]
5. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.
Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC
BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354
[TBL] [Abstract][Full Text] [Related]
6. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
[TBL] [Abstract][Full Text] [Related]
7. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
8. Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma.
Vishwamitra D; Shi P; Wilson D; Manshouri R; Vega F; Schlette EJ; Amin HM
Haematologica; 2011 Jun; 96(6):871-80. PubMed ID: 21330319
[TBL] [Abstract][Full Text] [Related]
9. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
10. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.
Dong L; Du M; Lv Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597
[TBL] [Abstract][Full Text] [Related]
11. Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma.
Karasic TB; Hei TK; Ivanov VN
Exp Cell Res; 2010 Jul; 316(12):1994-2007. PubMed ID: 20417200
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
[TBL] [Abstract][Full Text] [Related]
13. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
[TBL] [Abstract][Full Text] [Related]
14. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway.
Vasilcanu D; Girnita A; Girnita L; Vasilcanu R; Axelson M; Larsson O
Oncogene; 2004 Oct; 23(47):7854-62. PubMed ID: 15334055
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection.
Vasilcanu D; Weng WH; Girnita A; Lui WO; Vasilcanu R; Axelson M; Larsson O; Larsson C; Girnita L
Oncogene; 2006 May; 25(22):3186-95. PubMed ID: 16407828
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
[TBL] [Abstract][Full Text] [Related]
17. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model.
Yin SC; Guo W; Tao ZZ
Biochem Biophys Res Commun; 2013 Sep; 439(1):1-5. PubMed ID: 23973483
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.
Huang Z; Fang Z; Zhen H; Zhou L; Amin HM; Shi P
Leuk Lymphoma; 2014 Aug; 55(8):1876-83. PubMed ID: 24206093
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.
Menu E; Jernberg-Wiklund H; Stromberg T; De Raeve H; Girnita L; Larsson O; Axelson M; Asosingh K; Nilsson K; Van Camp B; Vanderkerken K
Blood; 2006 Jan; 107(2):655-60. PubMed ID: 16046527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
